Moreover, the same study reported a loss of caveolin-1 (a marker for breast cancer progression) in CAFs, attributed to mutations of BRCA1 as a result of high glycolysis in stromal cells [64]. This evidence concerns the gene BRCA1 and breast carcinoma.